Robert F. Kennedy Jr., a vocal critic of vaccines and obesity drugs, has taken over as head of the US Department of Health and Human Services. As part of his “Make America Healthy Again” movement, he’s set to make significant changes in the industry. Food and drug companies are watching closely, with some executives expressing optimism about reduced regulation under the new administration.
Kennedy’s stance on vaccines and obesity drugs has been well-documented, and he’s likely to bring these views to his role as health secretary. The pharmaceutical industry is bracing for potential policy shifts, including changes to vaccine distribution and weight-loss shot regulations. While some company executives have attempted to build relationships with the incoming administration through donations and Mar-a-Lago visits, it remains to be seen how their efforts will impact Kennedy’s policies.
The transition of power from one health secretary to another is a significant event in the US healthcare landscape, and its implications for vaccine policy, weight-loss shot regulations, and pharmaceutical advertising are still unclear.
Source: https://www.bloomberg.com/news/articles/2025-02-13/rfk-jr-confirmation-what-it-means-for-weight-loss-drugs-vaccines